코스피 이야기
Quickly browse recent reports in the selected category.
-
[KOSPI Story] 'KRW 4.5 Trillion War Chest and 35% TSR Drive' Hyundai Motor (005380): India Unit IPO Cash Inflow and Shareholder Return Scenarios
Hyundai Motor secures over KRW 3T in net cash from its record setting India unit HMIL IPO, fueling expectations for shareholder return targets includi...
-
[KOSPI Story] 'Hwaseong EVO Plant Online & North American HEV Surge' Kia (000270), Record Q3 Sales and PBV Transformation Scenario
Kia set a quarterly record in North America with 236,659 units sold in Q3, driven by a 77%+ jump in HEV sales. With its Hwaseong EVO Plant now active,...
-
[KOSPI Story] '440GWh Order Backlog and Arizona Ramp-up' LG Energy Solution (373220): Reviewing the 4680 Mass Production Timeline and North American Orders
LG Energy Solution is solidifying its North American lead by expanding its portfolio into 46 series cylindrical cells, securing over 440GWh in orders ...
-
[KOSPI Story] 'Securing Czech Dukovany Follow-up & Targeting Next-Gen U.S. Reactors' Doosan Enerbility (034020), Annual 13T KRW Order Track and K-Nuclear Export Cycle Review
Doosan Enerbility expands its SMR presence alongside detailed process talks for the Czech Dukovany project. Partnering with NuScale Power and TerraPow...
-
[KOSPI Stories] '784,000L Super-Gap and Biosecure Tailwinds': Samsung Biologics (207940) Targets Global CDMO Leadership as Plant 5 Ramps Up
Samsung Biologics 207940 solidifies its global CDMO dominance with Plant 5 and Rockville facilities. Benefiting from the U.S. Biosecure Act and strong...
-
[KOSPI Story] 'KRW 3.2T Jackpot & Commercialization of Korea's Own Obesity Drug': Hanmi Pharm (128940), Global Clinical Progress of H.O.P & H.M.P.A and Valuation Scenarios
Hanmi Pharm draws strong market focus as its H.O.P obesity pipeline advances globally, backed by a $2.3B Genentech deal for HM17321, upcoming domestic...